Aster DM Healthcare Limited has informed the Exchange about General Updates
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aster DM Healthcare's unsecured trade creditors have approved the proposed Scheme of Amalgamation with Quality Care India Limited (QCIL) at an NCLT-convened meeting held on March 10, 2026. The resolution was passed with 100% votes in favour — 206 unsecured trade creditors voted in support, representing 80.07% of the total unsecured debt value (approximately ₹68.04 crore in vote value), with zero votes against. The meeting was conducted via video conferencing and was overseen by an independent scrutinizer appointed by the NCLT Hyderabad Bench. This is a procedural milestone in the merger process, and the scheme still requires final NCLT sanction and other regulatory approvals to become effective.
Positive development for the merger pipeline as the scheme clears another key creditor approval hurdle. The stock is unlikely to see a sharp reaction from this procedural step, but it brings the amalgamation closer to completion, which could enhance Aster DM's scale and hospital network.